HomeCompareKIGRY vs JNJ

KIGRY vs JNJ: Dividend Comparison 2026

KIGRY yields 1.78% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KIGRY wins by $39.21M in total portfolio value
10 years
KIGRY
KIGRY
● Live price
1.78%
Share price
$13.15
Annual div
$0.23
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.24M
Annual income
$35,414,695.28
Full KIGRY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — KIGRY vs JNJ

📍 KIGRY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKIGRYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KIGRY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KIGRY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KIGRY
Annual income on $10K today (after 15% tax)
$151.33/yr
After 10yr DRIP, annual income (after tax)
$30,102,490.99/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, KIGRY beats the other by $30,098,505.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KIGRY + JNJ for your $10,000?

KIGRY: 50%JNJ: 50%
100% JNJ50/50100% KIGRY
Portfolio after 10yr
$19.63M
Annual income
$17,709,692.34/yr
Blended yield
90.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KIGRY
Analyst Ratings
4
Buy
1
Hold
Consensus: Buy
Altman Z
1.0
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KIGRY buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKIGRYJNJ
Forward yield1.78%2.13%
Annual dividend / share$0.23$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$39.24M$30.3K
Annual income after 10y$35,414,695.28$4,689.40
Total dividends collected$38.92M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: KIGRY vs JNJ ($10,000, DRIP)

YearKIGRY PortfolioKIGRY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,056$356.08$10,592$272.30+$464.00KIGRY
2$12,566$735.85$11,289$357.73+$1.3KKIGRY
3$15,009$1,563.25$12,123$472.89+$2.9KKIGRY
4$19,549$3,489.99$13,141$629.86+$6.4KKIGRY
5$29,415$8,496.87$14,408$846.81+$15.0KKIGRY
6$55,370$23,896.67$16,021$1,151.60+$39.3KKIGRY
7$143,327$84,080.86$18,122$1,588.22+$125.2KKIGRY
8$560,173$406,812.82$20,930$2,228.20+$539.2KKIGRY
9$3,571,287$2,971,902.38$24,792$3,191.91+$3.55MKIGRY
10$39,235,973$35,414,695.28$30,274$4,689.40+$39.21MKIGRY

KIGRY vs JNJ: Complete Analysis 2026

KIGRYStock

KION Group AG provides industrial trucks, warehouse technology, supply chain solutions, and related services worldwide. The company operates through Industrial Trucks & Services, and Supply Chain Solutions segments. It develops, manufactures, and sells forklift and warehouse trucks, such as counterbalance trucks with electric drive and internal combustion engine, ride-on and hand-operated industrial trucks, and towing vehicles under the Linde, Fenwick, STILL, Baoli, and OM brand names. The company also manufactures and sells spare parts; leases industrial trucks and related items; offers maintenance and repair, and fleet management services, as well as provides finance solutions. In addition, it provides integrated technology and software solutions, including conveyors, sorters, storage and retrieval systems, picking equipment, palletizers, and automated guided vehicle systems under the Dematic brand. The company was formerly known as KION Holding 1 GmbH. KION GROUP AG was founded in 2006 and is based in Frankfurt am Main, Germany.

Full KIGRY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this KIGRY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KIGRY vs SCHDKIGRY vs JEPIKIGRY vs OKIGRY vs KOKIGRY vs MAINKIGRY vs ABBVKIGRY vs MRKKIGRY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.